Trials / Completed
CompletedNCT00629564
An Open, Randomized, Two Way Crossover Study Comparing the Effect of 20mg Esomeprazole Administered Orally and Intravenously as a 15 Minute Infusion on Basal and Pentagastrin-Stimulated Acid Output in Subjects With Symptoms of Gastroesophageal Reflux Disease (GERD)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- AstraZeneca · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study looks at the effect on basal and pentagastrin-stimulated acid output of 40 mg Esomeprazole (Nexium) administered orally and intravenously as a 15-minute infusion to people with symptoms of Gastroesophageal Reflux Disease (GERD)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Esomeprazole | 20mg oral |
| DRUG | Esomeprazole | 15 minute intravenous infusion |
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2002-10-01
- Completion
- 2002-10-01
- First posted
- 2008-03-06
- Last updated
- 2011-01-25
Source: ClinicalTrials.gov record NCT00629564. Inclusion in this directory is not an endorsement.